Fresenius Kabi Limited

Business Development Manager

Job Locations UK-Bristol
Posted Date 3 weeks ago(18/04/2024 14:48)
Job ID
2024-1750
# of Openings
1
Category
Sales

Overview

The Company

Fresenius Kabi is a global healthcare company that specialises in lifesaving medicines and technologies. Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies, biosimilars and clinical nutrition products as well as the medical devices for administering these products.

The Fresenius Group employs over 300,000 high-calibre professionals across the world, with a workforce of circa. 1,000 across the UK and Ireland.

 

Overview of Role

We are looking for a Business Development Manager in the South West and Wales area.

This position reports in to the National Sales Manager (NSM) within the Parenteral Nutrition (PN) team and will be an integral part of a multi-disciplinary sales team.

The main focus of the role will be the promotion and profitable sales of the Fresenius Kabi Parenteral Nutrition (PN) product range and supporting services.

Responsibilities

• Promotion of the PN portfolio to key customers in the secondary care setting with the aim to exceed sales versus target for promotional priorities
• Develop and implement business plans and strategies for both Fresenius Kabi and competitor key accounts

• Work with NSM and marketing to develop successful sales strategies in your designated key accounts
• Attend seminars, exhibitions or meetings as directed by the NSM
• Maintain a high level of knowledge of customers, accounts, services, changes within the PN market and all relevant clinical developments

Qualifications

• Life science degree or equivalent (desirable, not essential)
• Clinical/technical background in pharmaceutical/healthcare sales or the NHS
• ABPI accreditation (desirable, not essential)
• Demonstrate good business acumen
• Team player
• Excellent communication and interpersonal skills

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed